NCT01114828View on ClinicalTrials.gov

A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

December 31, 2011

Conditions
Cirrhosis
Interventions
DRUG

OPC-41061

Once-daily oral administration of OPC-41061 at 3.75 mg after breakfast for 7 days

DRUG

OPC-41061

Once-daily oral administration of OPC-41061 at 7.5 mg after breakfast for 7 days

Trial Locations (1)

Unknown

Tokyo, Et Al.

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY